Dana Brown
Also at ICAD Inc
About
This executive has forged a diverse career spanning the technology, healthcare, and nonprofit sectors, developing a strong foundation during early roles at Texas Instruments and Arthur Andersen. Building on this experience, the individual held significant leadership roles in innovative companies and nonprofit organizations, contributing to strategic initiatives and transformative projects across various industries.
The professional journey includes entrepreneurial ventures as a co-founder and key executive at MetaSolv Software and Ipsum Networks, where pivotal contributions in marketing, strategic planning, and operational leadership were instrumental in pursuing growth opportunities and successful acquisitions.
At iCAD, the trajectory continued with a board appointment in January 2022, followed by a promotion to Chair in January 2023 and ultimately the appointment as CEO and President on March 10, 2023. The focus remains on delivering pioneering AI cancer detection solutions that aim to improve patient outcomes and drive meaningful change in the healthcare industry.
$ICAD Performance Under Dana Brown
Past Roles
Organization | Role | Date Range | Details |
---|---|---|---|
iCAD | Chair of the Board | January 2023 - March 2023 | Preceded her appointment as CEO, President, and Chair of the Board |
iCAD | Director | January 2022 | Served in this role before her CEO appointment in March 2023 |
Susan G. Komen® | Strategic Advisor and Senior VP, Chief Strategy and Operations Officer | November 2018 - April 2022 | World's leading nonprofit breast cancer organization |
United Way Worldwide | Senior Vice President and Chief Digital Officer | N/A | Global network of over 1,800 nonprofit fundraising affiliates |
MetaSolv Software | Co-founder and Chief Marketing Officer | N/A | Company later acquired by Oracle |
Ipsum Networks | Chief Executive Officer | N/A | One of the ventures she led |
Texas Instruments Incorporated | Early career position | N/A | Global technology company |
Arthur Andersen | Early career position | N/A | Global accounting firm |
Fixed Compensation
Component Name | Amount | Payment Schedule | Additional Details |
---|---|---|---|
Base Salary | $315,385 | Annual | Base fixed salary for 2023 |
All Other Compensation | $12,569 | Annual | Includes 401(k) matching contributions ($9,750 ) and Life insurance premiums ($2,819 ) |
Performance Compensation
Bonus Plan
Metric (Unit) | Value (Note) |
---|---|
Eligible Bonus | $120,000 |
Base Salary for Calculation | $400,000 |
Performance Metrics | Not disclosed |
Evaluation Period | Plan Year 2023 |
Outcome | Targets not met; no bonus paid |
Stock Option Awards
Metric (Unit) | Value (Note) |
---|---|
Options Granted | 250,000 shares |
Vesting Schedule | 3-year vesting |
Expiration Period | 10-year |
Grant Date Fair Value | Computed as per ASC Topic 718; specific value not provided |
Grant Date Stock Price | Not specified |
Performance Metrics/Conditions | Not specified; standard performance goals were referenced but details were not provided |